{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:05:56Z","timestamp":1793127956046,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier","isbn-type":[{"value":"9780443293245","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.apha.2024.04.002","type":"book-chapter","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T20:36:10Z","timestamp":1715718970000},"page":"209-246","source":"Crossref","is-referenced-by-count":14,"title":["Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy"],"prefix":"10.1016","author":[{"given":"Caroline K.","family":"S\u00f8gaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Otterlei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.bmc.2013.01.022","article-title":"Small molecule inhibitors of PCNA\/PIP-box interaction suppress translesion DNA synthesis","volume":"21","author":"Actis","year":"2013","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2024.04.002_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fmolb.2018.00087","article-title":"DNA sliding clamps as therapeutic targets","volume":"5","author":"Altieri","year":"2018","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10.1016\/bs.apha.2024.04.002_bib4","article-title":"G-CSF reshapes the cytosolic PCNA scaffold and modulates glycolysis in neutrophils","author":"Aymonnier","year":"2023","journal-title":"Journal of Leukocyte Biology"},{"issue":"13","key":"10.1016\/bs.apha.2024.04.002_bib5","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1093\/nar\/gkt397","article-title":"The helicase FBH1 is tightly regulated by PCNA via CRL4(Cdt2)-mediated proteolysis in human cells","volume":"41","author":"Bacquin","year":"2013","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.peptides.2006.12.013","article-title":"A sychnological cell penetrating peptide mimic of p21(WAF1\/CIP1) is pro-apoptogenic","volume":"28","author":"Baker","year":"2007","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib7","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1172\/JCI74593","article-title":"Hypomorphic PCNA mutation underlies a human DNA repair disorder","volume":"124","author":"Baple","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.18097\/PBMC20176304356","article-title":"[Quaternary structures of human cytoplasmic and nuclear PCNA are the same]","volume":"63","author":"Belyakova","year":"2017","journal-title":"Biomeditsinskaia Khimiia"},{"issue":"5755","key":"10.1016\/bs.apha.2024.04.002_bib9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1126\/science.1120615","article-title":"Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis","volume":"310","author":"Bienko","year":"2005","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molcel.2016.10.033","article-title":"Acetylation of PCNA sliding surface by Eco1 promotes genome stability through homologous recombination","volume":"65","author":"Billon","year":"2017","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.apha.2024.04.002_bib11","first-page":"17","article-title":"Olaparib for the treatment of ovarian cancer","volume":"52","author":"Bornstein","year":"2016"},{"issue":"12","key":"10.1016\/bs.apha.2024.04.002_bib12","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.str.2004.09.018","article-title":"Structural and thermodynamic analysis of human PCNA with peptides derived from DNA polymerase-delta p66 subunit and flap endonuclease-1","volume":"12","author":"Bruning","year":"2004","journal-title":"Structure (London, England: 1993)"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1568009620666200115162814","article-title":"Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation","volume":"20","author":"Cardano","year":"2020","journal-title":"Current Cancer Drug Targets"},{"issue":"13","key":"10.1016\/bs.apha.2024.04.002_bib14","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1093\/nar\/gku533","article-title":"CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis","volume":"42","author":"Cazzalini","year":"2014","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020129","article-title":"Targeting non-oncogene addiction for cancer therapy","volume":"11","author":"Chang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/bs.apha.2024.04.002_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.148","article-title":"Mitosis-targeted anti-cancer therapies: Where they stand","volume":"3","author":"Chan","year":"2012","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: A novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"key":"10.1016\/bs.apha.2024.04.002_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fimmu.2012.00311","article-title":"Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation","volume":"3","author":"Chiara","year":"2012","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2016.12.020","article-title":"Forging ahead through darkness: PCNA, still the principal conductor at the replication fork","volume":"65","author":"Choe","year":"2017","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.apha.2024.04.002_bib20","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/ncomms6931","article-title":"FBH1 influences DNA replication fork stability and homologous recombination through ubiquitylation of RAD51","volume":"6","author":"Chu","year":"2015","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.molcel.2012.05.024","article-title":"Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress","volume":"47","author":"Ciccia","year":"2012","journal-title":"Molecular Cell"},{"issue":"10","key":"10.1016\/bs.apha.2024.04.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108831","article-title":"Blockade of 6-phosphogluconate dehydrogenase generates CD8(+) effector T cells with enhanced anti-tumor function","volume":"34","author":"Daneshmandi","year":"2021","journal-title":"Cell Reports"},{"key":"10.1016\/bs.apha.2024.04.002_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.dnarep.2018.04.004","article-title":"Advances in therapeutic targeting of the DNA damage response in cancer","volume":"66-67","author":"Desai","year":"2018","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.115","article-title":"Target validation and structure-activity analysis of a series of novel PCNA inhibitors","volume":"3","author":"Dillehay","year":"2015","journal-title":"Pharmacology Research & Perspectives"},{"issue":"48","key":"10.1016\/bs.apha.2024.04.002_bib25","doi-asserted-by":"crossref","first-page":"20786","DOI":"10.1073\/pnas.1011409107","article-title":"Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy","volume":"107","author":"Doles","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191115","article-title":"\u03b2-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion","volume":"217","author":"Du","year":"2020","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jmb.2015.11.029","article-title":"A disease-causing variant in PCNA disrupts a promiscuous protein binding site","volume":"428","author":"Duffy","year":"2016","journal-title":"Journal of Molecular Biology"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004419","article-title":"The transcription factor TFII-I promotes DNA translesion synthesis and genomic stability","volume":"10","author":"Fattah","year":"2014","journal-title":"PLoS Genetics"},{"issue":"7973","key":"10.1016\/bs.apha.2024.04.002_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-023-06341-9","article-title":"RNA polymerase II associates with active genes during DNA replication","volume":"620","author":"Fenstermaker","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/2159-8290.CD-NB2018-008","article-title":"First PARP Inhibitor Ok\u2019d for Breast Cancer","volume":"8","year":"2018","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib31","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"American journal of cancer research"},{"issue":"41","key":"10.1016\/bs.apha.2024.04.002_bib32","doi-asserted-by":"crossref","first-page":"39265","DOI":"10.1074\/jbc.C300098200","article-title":"Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1\/cip1. A dynamic exchange of partners","volume":"278","author":"Frouin","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2024.04.002_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.dnarep.2015.09.008","article-title":"The interaction between ALKBH2 DNA repair enzyme and PCNA is direct, mediated by the hydrophobic pocket of PCNA and perturbed in naturally-occurring ALKBH2 variants","volume":"35","author":"Fu","year":"2015","journal-title":"DNA Repair (Amst)"},{"issue":"10","key":"10.1016\/bs.apha.2024.04.002_bib34","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.celrep.2015.02.028","article-title":"FBH1 catalyzes regression of stalled replication forks","volume":"10","author":"Fugger","year":"2015","journal-title":"Cell Reports"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib35","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.apha.2024.04.002_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2016.02.003","article-title":"DNA repair targeted therapy: The past or future of cancer treatment?","volume":"160","author":"Gavande","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.tranon.2014.10.005","article-title":"Increased anticancer efficacy of intravesical mitomycin C therapy when combined with a PCNA targeting peptide","volume":"7","author":"Gederaas","year":"2014","journal-title":"Translational Oncology"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib38","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.tranon.2014.10.005","article-title":"Increased anticancer efficacy of intravesical mitomycin C therapy when combined with a PCNA targeting peptide","volume":"7","author":"Gederaas","year":"2014","journal-title":"Translational Oncology"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1083\/jcb.200903138","article-title":"Identification of a novel, widespread, and functionally important PCNA-binding motif","volume":"186","author":"Gilljam","year":"2009","journal-title":"The Journal of Cell Biology"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049199","article-title":"Nucleotide excision repair is associated with the replisome and its efficiency depends on a direct interaction between XPA and PCNA","volume":"7","author":"Gilljam","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40164-022-00371-1","article-title":"Caspase-8 contributes to an immuno-hot microenvironment by promoting phagocytosis via an ecto-calreticulin-dependent mechanism","volume":"12","author":"Gong","year":"2023","journal-title":"Experimental Hematology & Oncology"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040570","article-title":"Human PCNA structure, function and interactions","volume":"10","author":"Gonz\u00e1lez-Maga\u00f1a","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/bs.apha.2024.04.002_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.biochem.71.083101.124707","article-title":"Error-prone repair DNA polymerases in prokaryotes and eukaryotes","volume":"71","author":"Goodman","year":"2002","journal-title":"Annual Review of Biochemistry"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020289","article-title":"ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma","volume":"14","author":"Gravina","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/bs.apha.2024.04.002_bib45","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.4161\/15384101.2014.969994","article-title":"PCNA mutation affects DNA repair not replication","volume":"13","author":"Green","year":"2014","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib46","first-page":"365","article-title":"NEDDylation antagonizes ubiquitination of proliferating cell nuclear antigen and regulates the recruitment of polymerase eta in response to oxidative DNA damage","volume":"9","author":"Guan","year":"2018","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0092-8674(00)81347-1","article-title":"Structure of the C-terminal region of p21(WAF1\/CIP1) complexed with human PCNA","volume":"87","author":"Gulbis","year":"1996","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2006.05.038","article-title":"REV1 protein interacts with PCNA: Significance of the REV1 BRCT domain in vitro and in vivo","volume":"23","author":"Guo","year":"2006","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.apha.2024.04.002_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2023.07.001","article-title":"Small molecule targeting of transcription-replication conflict for selective chemotherapy","author":"Gu","year":"2023","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/bs.apha.2024.04.002_bib50","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-18-0592","article-title":"The anticancer activity of a first-in-class small-molecule targeting PCNA","author":"Gu","year":"2018","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094773","article-title":"A PCNA-derived cell permeable peptide selectively inhibits neuroblastoma cell growth","volume":"9","author":"Gu","year":"2014","journal-title":"PLoS One"},{"issue":"Pt 4","key":"10.1016\/bs.apha.2024.04.002_bib52","first-page":"214","article-title":"Structure of proliferating cell nuclear antigen (PCNA) bound to an APIM peptide reveals the universality of PCNA interaction","volume":"74","author":"Hara","year":"2018","journal-title":"Acta Crystallographica Section F:Structural Biology Communications"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib53","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/MCB.25.3.1183-1190.2005","article-title":"A single domain in human DNA polymerase iota mediates interaction with PCNA: Implications for translesion DNA synthesis","volume":"25","author":"Haracska","year":"2005","journal-title":"Molecular and Cellular Biology"},{"issue":"21","key":"10.1016\/bs.apha.2024.04.002_bib54","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1128\/MCB.21.21.7199-7206.2001","article-title":"Physical and functional interactions of human DNA polymerase eta with PCNA","volume":"21","author":"Haracska","year":"2001","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nature Reviews. Cancer"},{"issue":"6903","key":"10.1016\/bs.apha.2024.04.002_bib57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nature00991","article-title":"RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO","volume":"419","author":"Hoege","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/cbic.201900275","article-title":"Targeting PCNA with peptide mimetics for therapeutic purposes","volume":"21","author":"Horsfall","year":"2020","journal-title":"Chembiochem: A European Journal of Chemical Biology"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059552","article-title":"Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44","volume":"8","author":"Horton","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ncb1378","article-title":"Regulation of monoubiquitinated PCNA by DUB autocleavage","volume":"8","author":"Huang","year":"2006","journal-title":"Nature Cell Biology"},{"issue":"10","key":"10.1016\/bs.apha.2024.04.002_bib61","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1074\/jbc.M113.520429","article-title":"A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin","volume":"289","author":"Inoue","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2024.04.002_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Molecular Biology International"},{"key":"10.1016\/bs.apha.2024.04.002_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-5956-8-22","article-title":"Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry","volume":"8","author":"Isabelle","year":"2010","journal-title":"Proteome Science"},{"key":"10.1016\/bs.apha.2024.04.002_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrfmmm.2017.06.004","article-title":"Regulation of DNA damage tolerance in mammalian cells by post-translational modifications of PCNA","volume":"803-805","author":"Kanao","year":"2017","journal-title":"Mutation Research"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1097-2765(04)00259-X","article-title":"Interaction of human DNA polymerase eta with monoubiquitinated PCNA: A possible mechanism for the polymerase switch in response to DNA damage","volume":"14","author":"Kannouche","year":"2004","journal-title":"Molecular Cell"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib66","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation","volume":"33","author":"Kaufman","year":"2015","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"20","key":"10.1016\/bs.apha.2024.04.002_bib67","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1021\/acs.jmedchem.6b00596","article-title":"Targeting the translesion synthesis pathway for the development of anti-cancer chemotherapeutics","volume":"59","author":"Korzhnev","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/nar\/gkx1184","article-title":"Inhibition of DNA replication by an anti-PCNA aptamer\/PCNA complex","volume":"46","author":"Kowalska","year":"2018","journal-title":"Nucleic Acids Research"},{"issue":"22","key":"10.1016\/bs.apha.2024.04.002_bib69","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1021\/acs.biochem.5b00241","article-title":"p21 exploits residue Tyr151 as a tether for high-affinity PCNA binding","volume":"54","author":"Kroker","year":"2015","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib70","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/2326-6066.CIR-19-0023","article-title":"Inhibition of the NKp44-PCNA immune checkpoint using a mAb to PCNA","volume":"7","author":"Kundu","year":"2019","journal-title":"Cancer Immunology Research"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5114\/ceji.2018.76273","article-title":"Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor \u03b2 on cancer cells","volume":"44","author":"Kwa\u015bniak","year":"2019","journal-title":"Central European Journal of Immunology"},{"key":"10.1016\/bs.apha.2024.04.002_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"Journal of Immunology Research"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib73","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.dnarep.2007.02.003","article-title":"Translesion synthesis: Y-family polymerases and the polymerase switch","volume":"6","author":"Lehmann","year":"2007","journal-title":"DNA Repair (Amst)"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41388-022-02582-6","article-title":"ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 study","volume":"42","author":"Lemech","year":"2023","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/genes10010010","article-title":"Mechanisms of DNA damage tolerance: Post-translational regulation of PCNA","volume":"10","author":"Leung","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/bs.apha.2024.04.002_bib76","article-title":"KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer","author":"Liang","year":"2020","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02031-20","article-title":"Toxoplasma gondii extends the life span of infected human neutrophils by inducing cytosolic PCNA and blocking activation of apoptotic caspases","volume":"12","author":"Lima","year":"2021","journal-title":"mBio"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2011.02.026","article-title":"SHPRH and HLTF act in a damage-specific manner to coordinate different forms of postreplication repair and prevent mutagenesis","volume":"42","author":"Lin","year":"2011","journal-title":"Molecular Cell"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib79","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00280-014-2574-x","article-title":"Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance","volume":"74","author":"Lingeman","year":"2014","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib80","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4161\/cc.9.4.10727","article-title":"Multiple two-polymerase mechanisms in mammalian translesion DNA synthesis","volume":"9","author":"Livneh","year":"2010","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","article-title":"Natural killer cells as an initial defense against pathogens","volume":"18","author":"Lodoen","year":"2006","journal-title":"Current Opinion in Immunology"},{"issue":"Pt 15","key":"10.1016\/bs.apha.2024.04.002_bib82","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): A dancer with many partners","volume":"116","author":"Maga","year":"2003","journal-title":"Journal of Cell Science"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib83","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrm3562","article-title":"Regulation of PCNA-protein interactions for genome stability","volume":"14","author":"Mailand","year":"2013","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"16","key":"10.1016\/bs.apha.2024.04.002_bib84","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1093\/nar\/gkv712","article-title":"Different types of interaction between PCNA and PIP boxes contribute to distinct cellular functions of Y-family DNA polymerases","volume":"43","author":"Masuda","year":"2015","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/excr.2001.5160","article-title":"Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein","volume":"265","author":"Mattock","year":"2001","journal-title":"Experimental Cell Research"},{"issue":"7713","key":"10.1016\/bs.apha.2024.04.002_bib86","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-018-0261-5","article-title":"High speed of fork progression induces DNA replication stress and genomic instability","volume":"559","author":"Maya-Mendoza","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib87","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.celrep.2018.01.040","article-title":"Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions","volume":"22","author":"Menk","year":"2018","journal-title":"Cell Reports"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib88","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2007.05.003","article-title":"PCNA, the maestro of the replication fork","volume":"129","author":"Moldovan","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molcel.2011.11.010","article-title":"Inhibition of homologous recombination by the PCNA-interacting protein PARI","volume":"45","author":"Moldovan","year":"2012","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.apha.2024.04.002_bib90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annual Review of Immunology"},{"issue":"34","key":"10.1016\/bs.apha.2024.04.002_bib91","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.1073\/pnas.0805685105","article-title":"Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks","volume":"105","author":"Motegi","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib92","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.200606145","article-title":"Human SHPRH suppresses genomic instability through proliferating cell nuclear antigen polyubiquitination","volume":"175","author":"Motegi","year":"2006","journal-title":"The Journal of Cell Biology"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib93","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/joim.12470","article-title":"The immune system and cancer evasion strategies: therapeutic concepts","volume":"279","author":"Muenst","year":"2016","journal-title":"Journal of Internal Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070430","article-title":"Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells","volume":"8","author":"Muller","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070430","article-title":"Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells","volume":"8","author":"M\u00fcller","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/bs.apha.2024.04.002_bib96","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1016\/j.febslet.2010.09.021","article-title":"Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer","volume":"584","author":"Naryzhny","year":"2010","journal-title":"FEBS Letters"},{"issue":"23","key":"10.1016\/bs.apha.2024.04.002_bib97","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1007\/s00018-008-8305-x","article-title":"Proliferating cell nuclear antigen: A proteomics view","volume":"65","author":"Naryzhny","year":"2008","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx059","article-title":"Drugging the cancers addicted to DNA repair","volume":"109","author":"Nickoloff","year":"2017","journal-title":"Journal of the National Cancer Institute"},{"issue":"42","key":"10.1016\/bs.apha.2024.04.002_bib99","doi-asserted-by":"crossref","first-page":"16125","DOI":"10.1073\/pnas.0802727105","article-title":"Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells","volume":"105","author":"Niimi","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt 1","key":"10.1016\/bs.apha.2024.04.002_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1242\/jcs.01603","article-title":"Localisation of human Y-family DNA polymerase kappa: Relationship to PCNA foci","volume":"118","author":"Ogi","year":"2005","journal-title":"Journal of Cell Science"},{"key":"10.1016\/bs.apha.2024.04.002_bib101","doi-asserted-by":"crossref","first-page":"35561","DOI":"10.1038\/srep35561","article-title":"Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia","volume":"6","author":"Ohayon","year":"2016","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib102","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1084\/jem.20180371","article-title":"Cytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils","volume":"216","author":"Ohayon","year":"2019","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib103","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.cellsig.2015.03.009","article-title":"PCNA-interacting peptides reduce Akt phosphorylation and TLR-mediated cytokine secretion suggesting a role of PCNA in cellular signaling","volume":"27","author":"Olaisen","year":"2015","journal-title":"Cellular Signalling"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib104","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/2211-5463.12442","article-title":"The role of PCNA as a scaffold protein in cellular signaling is functionally conserved between yeast and humans","volume":"8","author":"Olaisen","year":"2018","journal-title":"FEBS Open Bio"},{"issue":"18","key":"10.1016\/bs.apha.2024.04.002_bib105","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1073\/pnas.1417711112","article-title":"Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis","volume":"112","author":"Ortega","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib106","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.molcel.2014.03.031","article-title":"Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis","volume":"54","author":"Park","year":"2014","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.apha.2024.04.002_bib107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2019.00719","article-title":"NKp44-NKp44 ligand interactions in the regulation of natural killer cells and other innate lymphoid cells in humans","volume":"10","author":"Parodi","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"17","key":"10.1016\/bs.apha.2024.04.002_bib108","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1074\/jbc.RA119.007897","article-title":"Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM\/Akt\/GSK3\u03b2\/Snail signaling pathway","volume":"294","author":"Peng","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"issue":"24","key":"10.1016\/bs.apha.2024.04.002_bib109","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1007\/s00018-019-03150-0","article-title":"The PCNA interaction motifs revisited: Thinking outside the PIP-box","volume":"76","author":"Prestel","year":"2019","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/febs.13574","article-title":"Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies","volume":"283","author":"Puigvert","year":"2016","journal-title":"The FEBS Journal"},{"issue":"17","key":"10.1016\/bs.apha.2024.04.002_bib111","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1074\/jbc.M112.353201","article-title":"Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication","volume":"287","author":"Punchihewa","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010100","article-title":"APIM-mediated REV3L(-)PCNA interaction important for error free TLS over UV-induced DNA lesions in human cells","volume":"20","author":"Raeder","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/bs.apha.2024.04.002_bib113","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib114","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/onci.19366","article-title":"A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen","volume":"1","author":"Rosental","year":"2012","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib115","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.1102267","article-title":"Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44","volume":"187","author":"Rosental","year":"2011","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib116","first-page":"100","article-title":"APIM-mediated REV3L\u2013PCNA interaction important for error free TLS over UV-induced DNA lesions in human cells","volume":"20","author":"R\u00e6der","year":"2018"},{"issue":"8","key":"10.1016\/bs.apha.2024.04.002_bib117","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41388-022-02579-1","article-title":"PCNA regulates primary metabolism by scaffolding metabolic enzymes","volume":"42","author":"R\u00f8st","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/bs.apha.2024.04.002_bib118","doi-asserted-by":"crossref","first-page":"15847","DOI":"10.1038\/ncomms15847","article-title":"Structural insights into the function of ZRANB3 in replication stress response","volume":"8","author":"Sebesta","year":"2017","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030693","article-title":"Helicase-like transcription factor HLTF and E3 ubiquitin ligase SHPRH confer DNA damage tolerance through direct interactions with proliferating cell nuclear antigen (PCNA)","volume":"21","author":"Seelinger","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030463","article-title":"The human RAD5 homologs, HLTF and SHPRH, have separate functions in DNA damage tolerance dependent on the DNA lesion type","volume":"10","author":"Seelinger","year":"2020","journal-title":"Biomolecules"},{"issue":"7658","key":"10.1016\/bs.apha.2024.04.002_bib121","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"Shaffer","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib122","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.cdd.4400626","article-title":"c-Abl: Activation and nuclear targets","volume":"7","author":"Shaul","year":"2000","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/bs.apha.2024.04.002_bib123","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3389\/fimmu.2018.01114","article-title":"NKp44-derived peptide binds proliferating cell nuclear antigen and mediates tumor cell death","volume":"9","author":"Shemesh","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/bs.apha.2024.04.002_bib124","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/genes9080416","article-title":"Maneuvers on PCNA rings during DNA replication and repair","volume":"9","author":"Slade","year":"2018","journal-title":"Genes"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.114.093211","article-title":"A Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer","volume":"87","author":"Smith","year":"2015","journal-title":"Molecular Pharmacology"},{"issue":"65","key":"10.1016\/bs.apha.2024.04.002_bib126","doi-asserted-by":"crossref","first-page":"32448","DOI":"10.18632\/oncotarget.25963","article-title":"Two hits\u2014One stone\u201d; increased efficacy of cisplatin-based therapies by targeting PCNA\u2019s role in both DNA repair and cellular signaling","volume":"9","author":"S\u00f8gaard","year":"2018","journal-title":"Oncotarget"},{"issue":"68","key":"10.1016\/bs.apha.2024.04.002_bib127","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.18632\/oncotarget.27267","article-title":"Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy","volume":"10","author":"S\u00f8gaard","year":"2019","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/bs.apha.2024.04.002_bib128","doi-asserted-by":"crossref","first-page":"11752","DOI":"10.18632\/oncotarget.24357","article-title":"APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer","volume":"9","author":"S\u00f8gaard","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/bs.apha.2024.04.002_bib129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/mol.112.077735","article-title":"Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth","volume":"81","author":"Tan","year":"2012","journal-title":"Molecular Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.dnarep.2009.01.006","article-title":"Regulating post-translational modifications of the eukaryotic replication clamp PCNA","volume":"8","author":"Ulrich","year":"2009","journal-title":"DNA Repair (Amst)"},{"issue":"10","key":"10.1016\/bs.apha.2024.04.002_bib131","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.0800563105","article-title":"Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination","volume":"105","author":"Unk","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"48","key":"10.1016\/bs.apha.2024.04.002_bib132","doi-asserted-by":"crossref","first-page":"18107","DOI":"10.1073\/pnas.0608595103","article-title":"Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen","volume":"103","author":"Unk","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2024.04.002_bib55","first-page":"1029","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009"},{"issue":"12","key":"10.1016\/bs.apha.2024.04.002_bib133","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib134","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.molcel.2017.08.010","article-title":"Replication fork slowing and reversal upon DNA damage require PCNA polyubiquitination and ZRANB3 DNA translocase activity","volume":"67","author":"Vujanovic","year":"2017","journal-title":"Molecular Cell"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib135","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2014.02.004","article-title":"PCNA: A silent housekeeper or a potential therapeutic target?","volume":"35","author":"Wang","year":"2014","journal-title":"Trends in Pharmacological Sciences"},{"issue":"12","key":"10.1016\/bs.apha.2024.04.002_bib136","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ncb1501","article-title":"Tyrosine phosphorylation controls PCNA function through protein stability","volume":"8","author":"Wang","year":"2006","journal-title":"Nature Cell Biology"},{"issue":"7","key":"10.1016\/bs.apha.2024.04.002_bib137","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1093\/nar\/gkaa096","article-title":"Site-specific proteolytic cleavage prevents ubiquitination and degradation of human REV3L, the catalytic subunit of DNA polymerase \u03b6","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R","article-title":"PCNA binding through a conserved motif","volume":"20","author":"Warbrick","year":"1998","journal-title":"Bioessays: News and Reviews in Molecular, Cellular and Developmental Biology"},{"issue":"20","key":"10.1016\/bs.apha.2024.04.002_bib139","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1038\/sj.onc.1209320","article-title":"A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design","volume":"25","author":"Warbrick","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/bs.apha.2024.04.002_bib140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0960-9822(95)00058-3","article-title":"A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen","volume":"5","author":"Warbrick","year":"1995","journal-title":"Current Biology: CB"},{"issue":"19","key":"10.1016\/bs.apha.2024.04.002_bib141","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/sj.emboj.7600383","article-title":"Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination","volume":"23","author":"Watanabe","year":"2004","journal-title":"The EMBO Journal"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib142","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"issue":"44","key":"10.1016\/bs.apha.2024.04.002_bib143","first-page":"11325","article-title":"Rational design of a 3(10)-helical PIP-box mimetic targeting PCNA, the human sliding clamp","volume":"24","author":"Wegener","year":"2018","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"issue":"12","key":"10.1016\/bs.apha.2024.04.002_bib144","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1084\/jem.20092241","article-title":"Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival","volume":"207","author":"Witko-Sarsat","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"issue":"21","key":"10.1016\/bs.apha.2024.04.002_bib145","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1158\/0008-5472.CAN-03-3942","article-title":"DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/bs.apha.2024.04.002_bib146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Letters"},{"issue":"48","key":"10.1016\/bs.apha.2024.04.002_bib147","doi-asserted-by":"crossref","first-page":"20792","DOI":"10.1073\/pnas.1011412107","article-title":"Error-prone translesion synthesis mediates acquired chemoresistance","volume":"107","author":"Xie","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.apha.2024.04.002_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006842","article-title":"Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?","volume":"13","author":"Yamanaka","year":"2017","journal-title":"PLoS Genetics"},{"key":"10.1016\/bs.apha.2024.04.002_bib149","doi-asserted-by":"crossref","first-page":"8459496","DOI":"10.1155\/2020\/8459496","article-title":"Overview of strategies to improve therapy against tumors using natural killer cell","volume":"2020","author":"Yang","year":"2020","journal-title":"Journal of Immunology Research"},{"issue":"12","key":"10.1016\/bs.apha.2024.04.002_bib150","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1200\/JCO.2011.37.6418","article-title":"Development of therapeutic combinations targeting major cancer signaling pathways","volume":"31","author":"Yap","year":"2013","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"2","key":"10.1016\/bs.apha.2024.04.002_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117546","article-title":"The S-nitrosylation status of PCNA localized in cytosol impacts the apoptotic pathway in a Parkinson\u2019s disease paradigm","volume":"10","author":"Yin","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apha.2024.04.002_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061362","article-title":"Targeting the EGFR\/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/bs.apha.2024.04.002_bib153","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.7150\/ijbs.64628","article-title":"Post-translational modifications of PCNA in control of DNA synthesis and DNA damage tolerance-the implications in carcinogenesis","volume":"17","author":"Zhang","year":"2021","journal-title":"International Journal of Biological Sciences"},{"issue":"11","key":"10.1016\/bs.apha.2024.04.002_bib154","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/onc.2013.84","article-title":"The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer","volume":"33","author":"Zhao","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029416","article-title":"Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.apha.2024.04.002_bib156","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/1535-7163.MCT-10-0778","article-title":"Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth","volume":"10","author":"Zhao","year":"2011","journal-title":"Molecular Cancer Therapeutics"},{"issue":"5","key":"10.1016\/bs.apha.2024.04.002_bib157","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3892\/ol.2014.1943","article-title":"Post-translational modifications of proliferating cell nuclear antigen: A key signal integrator for DNA damage response (review)","volume":"7","author":"Zhu","year":"2014","journal-title":"Oncology Letters"}],"container-title":["Advances in Pharmacology","The Discovery of New Medicines in Academia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T14:07:10Z","timestamp":1721398030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358924000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443293245"],"references-count":157,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2024.04.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}